Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Cipla Limited

Market Cap 1,117B 11.67B 10.14B 9.27B 8.7B 16.35B 16.55B 110B 43.04B 539B 43.81B 42.86B 1,874B P/E Ratio 2027 *
26.7x
P/E Ratio 2028 * 21.8x
Enterprise Value 1,019B 10.64B 9.24B 8.45B 7.93B 14.9B 15.09B 100B 39.24B 492B 39.94B 39.08B 1,708B EV / Sales 2027 *
3.28x
EV / Sales 2028 * 2.87x
Free-Float
65.43%
Yield 2027 *
0.9%
Yield 2028 * 1.02%
1 day+0.46%
1 week+0.59%
Current month-1.26%
1 month+2.69%
3 months+3.73%
6 months-7.22%
Current year-8.47%
1 week 1,371.1
Extreme 1371.1
1,406.1
1 month 1,274.7
Extreme 1274.7
1,444.5
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 955.15
Extreme 955.15
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
President - 2026-05-17
Director of Finance/CFO - 2022-08-15
Director TitleAgeSince
Chairman 89 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap.
24-08-21Sell 2,000 0.0002%
24-08-13Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+0.59%-8.44%+42.72% 11.68B
+0.44%+0.32%+6.24%+82.35% 44.99B
-0.44%-7.89%+40.02%+89.26% 33.69B
+0.69%+2.72%+12.64%+117.80% 11.6B
0.00%+0.39%+36.17%+125.55% 8.94B
-1.44%-2.92%+15.81%+39.35% 7.01B
+0.00%-1.36%+32.74%+237.16% 6.35B
+0.61%+3.68%+45.01%-16.20% 6.51B
-0.45%-3.68%-38.58%-6.82% 5.15B
+2.23%+7.31%+22.01%+116.03% 4.03B
Average +0.21%-0.34%+16.36%+82.72% 13.99B
Weighted average by Cap. +0.14%-1.62%+17.88%+84.38%

Financials

2027 *2028 *
Net sales 311B 3.24B 2.82B 2.58B 2.42B 4.54B 4.6B 30.58B 11.96B 150B 12.18B 11.91B 521B 346B 3.62B 3.14B 2.87B 2.7B 5.07B 5.13B 34.1B 13.34B 167B 13.58B 13.29B 581B
Net income 41.87B 437M 380M 347M 326M 612M 620M 4.12B 1.61B 20.21B 1.64B 1.61B 70.21B 51.21B 535M 465M 425M 399M 749M 758M 5.04B 1.97B 24.72B 2.01B 1.96B 85.87B
Net Debt -98.65B -1.03B -895M -818M -768M -1.44B -1.46B -9.71B -3.8B -47.61B -3.87B -3.78B -165B -125B -1.3B -1.13B -1.04B -972M -1.83B -1.85B -12.29B -4.81B -60.26B -4.9B -4.79B -209B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-06-11 1,383.30 +0.46% 654,474
26-06-10 1,377.00 +0.04% 962,642
26-06-09 1,376.50 -0.82% 1,419,845
26-06-08 1,387.90 -0.96% 669,481
26-06-05 1,401.30 +0.19% 1,050,391
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,383.30INR
Average target price
1,456.73INR
Spread / Average Target
+5.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!